• Ann Marie LeVine


Continuous Positive Airway Pressure Respiratory Syncytial Virus Respiratory Syncytial Virus Infection Ipratropium Bromide Intermittent Positive Pressure Ventilation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980–1996. JAMA 1999;282(15):1440–1446.PubMedCrossRefGoogle Scholar
  2. 2.
    Shay DK, Holman RC, Roosevelt GE, Clarke MJ, Anderson LJ. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997. J Infect Dis 2001;183(1):16–22.PubMedCrossRefGoogle Scholar
  3. 3.
    Welliver RC. Respiratory syncytial virus and other respiratory viruses. Pediatr Infect Dis J 2003;22(2 Suppl):S6–S12.PubMedGoogle Scholar
  4. 4.
    Ogra PL. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev 2004;5(Suppl A):S119–S126.PubMedCrossRefGoogle Scholar
  5. 5.
    Leader S, Kohlhase K. Respiratory syncytial virus-coded pediatric hospitalizations, 1997 to 1999. Pediatr Infect Dis J 2002;21(7):629–632.PubMedCrossRefGoogle Scholar
  6. 6.
    Meissner HC. Selected populations at increased risk from respiratory syncytial virus infection. Pediatr Infect Dis J 2003;22(2 Suppl):S40–S45.PubMedGoogle Scholar
  7. 7.
    Wang EE, Law BJ, Stephens D. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr 1995;126(2):212–219.PubMedCrossRefGoogle Scholar
  8. 8.
    Buckingham SC, Quasney MW, Bush AJ, DeVincenzo JP. Respiratory syncytial virus infections in the pediatric intensive care unit: clinical characteristics and risk factors for adverse outcomes. Pediatr Crit Care Med 2001;2(4):318–323.PubMedCrossRefGoogle Scholar
  9. 9.
    Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970;23(1):7–18.PubMedCrossRefGoogle Scholar
  10. 10.
    Gardner PS, Turk DC, Aherne WA, Bird T, Holdaway MD, Court SD. Deaths associated with respiratory tract infection in childhood. BMJ 1967;4(575):316–320.PubMedCrossRefGoogle Scholar
  11. 11.
    Englund J, Glezen WP, Piedra PA. Maternal immunization against viral disease. Vaccine 1998;16(14–15):1456–1463.PubMedCrossRefGoogle Scholar
  12. 12.
    McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J 2004;23(1):106–112.PubMedCrossRefGoogle Scholar
  13. 13.
    Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med 2003;168(6):633–639.PubMedCrossRefGoogle Scholar
  14. 14.
    Bont L, Aalderen WM, Kimpen JL. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis. Paediatr Respir Rev 2000;1(3):221–227.PubMedCrossRefGoogle Scholar
  15. 15.
    Hernandez E, Khoshoo V, Thoppil D, Edell D, Ross G. Aspiration: a factor in rapidly deteriorating bronchiolitis in previously healthy infants? Pediatr Pulmonol 2002;33(1):30–31.PubMedCrossRefGoogle Scholar
  16. 16.
    Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. J Pediatr 1988;113(2):266–271.PubMedCrossRefGoogle Scholar
  17. 17.
    Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J 1998;17(3):231–236.PubMedCrossRefGoogle Scholar
  18. 18.
    Lugo RA, Nahata MC. Pathogenesis and treatment of bronchiolitis. Clin Pharmacol 1993;12(2):95–116.Google Scholar
  19. 19.
    Barry W, Cockburn F, Cornall R, Price JF, Sutherland G, Vardag A. Ribavirin aerosol for acute bronchiolitis. Arch Dis Child 1986;61(6):593–597.PubMedCrossRefGoogle Scholar
  20. 20.
    Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics 1996;97(1):137–140.Google Scholar
  21. 21.
    Moler FW, Steinhart CM, Ohmit SE, Stidham GL. Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatric Critical Study Group. J Pediatr 1996;128(3):422–428.PubMedCrossRefGoogle Scholar
  22. 22.
    Guerguerian AM, Gauthier M, Lebel MH, Farrell CA, Lacroix J. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Am J Respir Crit Care Med 1999;160(3):829–834.PubMedGoogle Scholar
  23. 23.
    Krilov LR, Mandel FS, Barone SR, Fagin JC. Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. Pediatr Infect Dis J 1997;16(3):273–276.Google Scholar
  24. 24.
    Long CE, Voter KZ, Barker WH, Hall CB. Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Pediatr Infect Dis J 1997;16(11):1023–1028.PubMedCrossRefGoogle Scholar
  25. 25.
    Englund JA, Piedra PA, Ahn YM, Gilbert BE, Hiatt P. High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J Pediatr 1994;125(4):635–641.PubMedCrossRefGoogle Scholar
  26. 26.
    Rodriguez WJ, Gruber WC, Welliver RC, Groothuis JR, Simoes EA, Meissner HC, et al. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics 1997;99(3):454–461.PubMedCrossRefGoogle Scholar
  27. 27.
    The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102(3):531–537.CrossRefGoogle Scholar
  28. 28.
    Malley R, DeVincenzo J, Ramilo O, Dennehy PH, Meissner HC, Gruber WC, et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998;178(6):1555–1561.PubMedCrossRefGoogle Scholar
  29. 29.
    De Boeck K, Van der Aa N, Van Lierde S, Corbeel L, Eeckels R. Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. J Pediatr 1997;131(6):919–921.PubMedCrossRefGoogle Scholar
  30. 30.
    Richter H, Seddon P. Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. J Pediatr 1998;132(5):849–853.PubMedCrossRefGoogle Scholar
  31. 31.
    Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE, et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999;104(6):e77.PubMedCrossRefGoogle Scholar
  32. 32.
    Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002;140(1):27–32.PubMedCrossRefGoogle Scholar
  33. 33.
    Volovitz B, Welliver RC, De Castro G, Krystofik DA, Ogra PL. The release of leukotrienes in the respiratory tract during infection with respiratory syncytial virus: role in obstructive airway disease. Pediatr Res 1988;24(4):504–507.PubMedCrossRefGoogle Scholar
  34. 34.
    Bisgaard H. A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am J Respir Crit Care Med 2003;167(3):379–383.PubMedCrossRefGoogle Scholar
  35. 35.
    Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100(2 Pt 1):233–239.Google Scholar
  36. 36.
    Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children. Bronchiolitis and croup. Emerg Med Clin North Am 2002;20(1):93–114.PubMedCrossRefGoogle Scholar
  37. 37.
    Sanchez I, De Koster J, Powell RE, Wolstein R, Chernick V. Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J Pediatr 1993;122(1):145–151.PubMedCrossRefGoogle Scholar
  38. 38.
    Numa AH, Williams GD, Dakin CJ. The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolitis. Am J Respir Crit Care Med 2001;164(1):86–91.PubMedGoogle Scholar
  39. 39.
    Patel H, Platt RW, Pekeles GS, Ducharme FM. A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. J Pediatr 2002;141(6):818–824.PubMedCrossRefGoogle Scholar
  40. 40.
    Abul-Ainine A, Luyt D. Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch Dis Child 2002;86(4):276–279.PubMedCrossRefGoogle Scholar
  41. 41.
    Wainwright C, Altamirano L, Cheney M, Cheney J, Barber S, Price D, et al. A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003;349(1):27–35.PubMedCrossRefGoogle Scholar
  42. 42.
    Schuh S, Johnson D, Canny G, Reisman J, Shields M, Kovesi T, et al. Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics 1992;90(6):920–923.PubMedGoogle Scholar
  43. 43.
    Rubin BK, Albers GM. Use of anticholinergic bronchodilation in children. Am J Med 1996;100(1A):49S–53S.PubMedCrossRefGoogle Scholar
  44. 44.
    Papamoschou D. Theoretical validation of the respiratory benefits of helium-oxygen mixtures. Respir Physiol 1995;99(1):183–190.PubMedCrossRefGoogle Scholar
  45. 45.
    Hollman G, Shen G, Zeng L, Yngsdal-Krenz R, Perloff W, Zimmerman J, et al. Helium–oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit Care Med 1998;26(10):1731–1736.PubMedCrossRefGoogle Scholar
  46. 46.
    Martinon-Torres F, Rodriguez-Nunez A, Martinon-Sanchez JM. Heliox therapy in infants with acute bronchiolitis. Pediatrics 2002;109(1):68–73.PubMedCrossRefGoogle Scholar
  47. 47.
    Leclerc F, Riou Y, Martinot A, Storme L, Hue V, Flurin V, et al. Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive Care Med 1994;20(7):511–512.PubMedCrossRefGoogle Scholar
  48. 48.
    Hoehn T, Krause M, Krueger M, Hentschel R. Treatment of respiratory failure with inhaled nitric oxide and high-frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia. Respiration 1998;65(6):477–480.PubMedCrossRefGoogle Scholar
  49. 49.
    Patel NR, Hammer J, Nichani S, Numa A, Newth CJ. Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis. Intensive Care Med 1999;25(1):81–87.PubMedCrossRefGoogle Scholar
  50. 50.
    LeVine AM, Lotze A, Stanley S, Stroud C, O’Donnell R, Whitsett J, et al. Surfactant content in children with inflammatory lung disease. Crit Care Med 1996;24(6):1062–1067.PubMedCrossRefGoogle Scholar
  51. 51.
    Luchetti M, Ferrero F, Gallini C, Natale A, Pigna A, Tortorolo L, et al. Multicenter, randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr Crit Care Med 2002;3(3):261–268.PubMedCrossRefGoogle Scholar
  52. 52.
    Soong WJ, Hwang B, Tang RB. Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatr Pulmonol 1993;16(3):163–166.PubMedCrossRefGoogle Scholar
  53. 53.
    Duval EL, Leroy PL, Gemke RJ, van Vught AJ. High-frequency oscillatory ventilation in RSV bronchiolitis patients. Respir Med 1999;93(6):435–440.PubMedCrossRefGoogle Scholar
  54. 54.
    Khan JY, Kerr SJ, Tometzki A, Tyszczuk L, West J, Sosnowski A, et al. Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Arch Dis Child Fetal Neonatal Ed 1995;73(2):F91–F94.PubMedCrossRefGoogle Scholar
  55. 55.
    Madge P, Paton JY, McColl JH, Mackie PL. Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus. Lancet 1992;340(8827):1079–1083.PubMedCrossRefGoogle Scholar
  56. 56.
    Choi EH, Lee HJ, Yoo T, Chanock SJ. A common haplotype of interleukin-4 gene IL4 is associated with severe respiratory syncytial virus disease in Korean children. J Infect Dis 2002;186(9):1207–1211.PubMedCrossRefGoogle Scholar
  57. 57.
    Hacking D, Knight JC, Rockett K, Brown H, Frampton J, Kwiatkowski DP, et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun 2004;5(4):274–282.PubMedCrossRefGoogle Scholar
  58. 58.
    Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol 2001;2(8):732–738.PubMedCrossRefGoogle Scholar
  59. 59.
    Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 2000;1(5):398–401.PubMedCrossRefGoogle Scholar
  60. 60.
    Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, et al. Association between common toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J Infect Dis 2004;189(11):2057–2063.PubMedCrossRefGoogle Scholar
  61. 61.
    LeVine AM, Whitsett JA. Pulmonary collectins and innate host defense of the lung. Microbes Infect 2001;3(2):161–166.PubMedCrossRefGoogle Scholar
  62. 62.
    Lofgren J, Ramet M, Renko M, Marttila R, Hallman M. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants. J Infect Dis 2002;185(3):283–289.PubMedCrossRefGoogle Scholar
  63. 63.
    Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R, et al. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002;51(6):696–699.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2009

Authors and Affiliations

  • Ann Marie LeVine
    • 1
  1. 1.Division of Critical Care Medicine Shands Hospital for ChildrenUniversity of Florida College of MedicineGainesvilleUSA

Personalised recommendations